Circulating non-coding RNAs as a tool for liquid biopsy in solid tumors


Karaca Dogan B., Salman Yilmaz S., Izgi G. N., Özen M.

Epigenomics, cilt.17, sa.5, ss.335-358, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 17 Sayı: 5
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1080/17501911.2025.2467021
  • Dergi Adı: Epigenomics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Biotechnology Research Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.335-358
  • Anahtar Kelimeler: biomarkers, circulating, epigenetic regulations, lncRNA, microRNA, Non-coding RNAs, solid tumors
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Solid tumors are significant causes of global mortality and morbidity. Recent research has primarily concentrated on finding pathology-specific molecules that can be acquired non-invasively and that can change as the disease progresses or in response to treatment. The focus of research has moved to RNA molecules that are either freely circulating in body fluids or bundled in microvesicles and exosomes because of their great stability in challenging environments, ease of accessibility, and changes in level in response to therapy. In this context, there are many non-coding RNAs that can be used for this purpose in liquid biopsies. Out of these, microRNAs have been extensively studied. However, there has been an increase of interest in studying long non-coding RNAs, piwi interacting RNAs, circular RNAs, and other small non-coding RNAs. In this article, an overview of the most researched circulating non-coding RNAs in solid tumors will be reviewed, along with a discussion of the significance of these molecules for early diagnosis, prognosis, and therapeutic targets. The publications analyzed were extracted from the PubMed database between 2008 and June 2024.